Share
Share today's newsletter with a colleague
and get credit if they sign up for SmartBrief.
Referral Count:
0
Story being shared
New anti-clotting drug gets FDA approval
Bristol-Myers Squibb and Pfizer received federal approval for their Eliquis drug to treat atrial fibrillation in patients facing risk of stroke or blood clots.
USA Today/The Associated Press (12/28)
Or we can send an email on your behalf